Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113980028A details a novel organocatalytic route for chiral spiro indolones. This method offers mild conditions, high stereoselectivity, and scalable manufacturing for pharmaceutical intermediates.
Patent CN101717408B introduces a bis-phosphorus ylide ligand enabling high-yield alpha-arylation. This breakthrough offers significant cost reduction in API manufacturing and robust supply chain reliability.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN110452150A reveals efficient synthesis of axial chiral indole-naphthalene compounds. Offers cost reduction in specialty chemical manufacturing and reliable supply chain solutions.
Novel synthesis patent CN116199614B offers high enantioselectivity and cost-effective manufacturing for reliable pharmaceutical intermediates supplier partnerships ensuring supply chain continuity.
Patent CN102219739A reveals a high-yield FeCl3-catalyzed route to azaanthracenes, offering cost-effective manufacturing and reliable supply for pharmaceutical intermediates.
A novel two-step method for o-alkynyl phenylcyclobutanone and naphthalenone synthesis offering high yields and simplified purification for pharmaceutical supply chains.
Patent CN108003086B reveals a metal-free I2-TBHP catalytic system for 3-amino-2-indolones. This green method offers significant cost reduction and scalable manufacturing advantages.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction in API manufacturing.
Patent CN109265385B discloses a low-cost, high-yield synthesis of chiral diphenyl prolinol using sulfuric acid catalysis, offering significant supply chain advantages.
Patent CN117003678B reveals green iodide-catalyzed route for naphthylamine derivatives. Offers significant cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally without transition metals.
Novel patent CN108840785B details a green oxidative coupling method for alkynes, offering cost-effective routes for pharmaceutical and material intermediates.
Patent CN108033922A reveals metal-free synthesis for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with green chemistry.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN103664821B reveals mild protonic acid catalysis for benzothiazole. Offers cost reduction and supply reliability for pharma intermediates.
Novel metal-free oxidative cyclization route for high-purity pharmaceutical intermediates. Reduces synthetic steps and eliminates heavy metal contamination risks.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN102040564B reveals a safe, high-yield nucleophilic substitution route for 3-aminobenzo[d]isothiazole, offering significant cost reduction and supply chain stability for pharma manufacturing.
Patent CN105732619A reveals a one-step catalytic route for high-purity pharmaceutical intermediates, offering significant supply chain reliability and cost reduction advantages.
Novel chiral phosphoric acid catalysis enables high-purity indolo derivatives. This patent offers cost-effective scale-up solutions for global pharmaceutical intermediates manufacturing supply chains.